Ligand Pharmaceuticals (LGND)

NASDAQ: LGND · Real-Time Price · USD

109.02

-0.84 (-0.76%)

At close: May 01, 2025, 3:59 PM

110.00

0.90%

Pre-market: May 02, 2025, 09:06 AM EDT

Ligand Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	72.31M	22.95M	45.01K	19.52M	47.62M	1.01B	718.38M	201.66M	141.05M
Short-Term Investments	183.86M	147.35M	166.86K	321.59M	363.57M	58.34M	46.19M	181.04M	122.3M
Long-Term Investments	10.91M	48.32M	3M	n/a	n/a	-25.61M	601.22M	6.44M	8.35M
Other Long-Term Assets	202.53M	5.92M	14.22M	23.25M	18.7M	9.54M	-600.75M	4.86M	1.74M
Receivables	42.45M	39.31M	35.04M	91.65M	59.06M	41.75M	55.85M	25.6M	18.22M
Inventory	14.11M	23.97M	13.29M	27.33M	26.49M	7.3M	7.12M	4.37M	1.92M
Other Current Assets	16.9M	2.66M	2.27M	4.67M	3.82M	4.73M	89.19M	5.39M	n/a
Total Current Assets	331.56M	237.43M	263.6M	464.75M	500.56M	1.12B	870.54M	237.02M	163.05M
Property-Plant & Equipment	24.81M	25.06M	15.01M	32.75M	22.73M	10.35M	5.37M	4.21M	1.82M
Goodwill & Intangibles	371.9M	470.27M	458.31M	745.11M	795.97M	325.77M	337.9M	334.07M	302.73M
Total Long-Term Assets	610.22M	549.79M	499.07M	836.63M	861.73M	345.66M	390.26M	434M	438.53M
Total Assets	941.77M	787.22M	762.67M	1.3B	1.36B	1.47B	1.26B	671.02M	601.59M
Account Payables	5.23M	2.43M	5.31M	8.4M	3.78M	2.42M	4.18M	2.26M	2.73M
Deferred Revenue	1.28M	1.22M	355K	11M	29.43M	2.14M	3.29M	173K	n/a
Short-Term Debt	1.29M	n/a	76.69M	n/a	n/a	n/a	26.43M	224.53M	212.91M
Other Current Liabilities	6.35M	8.04M	9.54M	25.32M	49.6M	7.62M	44.3M	1.41M	5.09M
Total Current Liabilities	37.11M	16.78M	98.81M	41.66M	100.11M	17M	82.25M	238.87M	227.13M
Long-Term Debt	n/a	n/a	n/a	320.72M	442.29M	638.96M	609.86M	18.86M	29.56M
Other Long-Term Liabilities	41.7M	62.32M	25.38M	111.73M	40.12M	28.82M	7.78M	-8.88M	-25.96M
Total Long-Term Liabilities	74.22M	69.52M	66.37M	438.09M	552.65M	685.07M	617.64M	13.51M	3.6M
Total Liabilities	111.33M	86.3M	165.18M	479.75M	652.76M	702.08M	699.89M	252.37M	230.73M
Total Debt	7.11M	6.17M	87.75M	336.26M	454.53M	648.93M	636.3M	224.53M	212.91M
Common Stock	20K	18K	17.00	17K	16K	17K	21K	21K	21K
Retained Earnings	498.98M	503.02M	450.86K	449.09M	391.95M	400.11M	-229.2M	-400.92M	-431.13M
Comprehensive Income	-5.94M	-817K	-984	-917K	-801K	-216K	-1.02M	2.49M	2.74M
Shareholders Equity	830.44M	700.91M	597.49M	821.63M	709.52M	767.23M	560.91M	418.65M	370.85M
Total Investments	194.77M	195.68M	166.86K	321.59M	363.57M	58.34M	647.41M	187.48M	130.64M